We specifically examined the association between EZH2 expression and 10 key clinicopathological features of HCC, including patient demographics (age and sex), tumor stage (T, N, M), pathological stage, presence of residual tumor, histological grading, and OS events (Supplementary Fig. 2). This evidence concerns the gene EZH2 and hepatocellular carcinoma.